ORX750
Narcolepsy Type 1 (NT1)
Key Facts
About Centessa Pharmaceuticals
Centessa Pharmaceuticals is a clinical-stage biotech company with a mission to discover and develop transformational medicines for patients. Its core strategy revolves around a portfolio of orexin receptor 2 agonist programs, led by ORX750, targeting significant unmet needs in sleep-wake disorders and broader neuroscience indications. The company is led by a seasoned team of industry veterans and operates with a lean, asset-focused development model to drive programs from discovery to late-stage development efficiently.
View full company profileAbout Centessa Pharmaceuticals
Centessa Pharmaceuticals is a clinical-stage biotech company with a mission to discover and develop transformational medicines for patients. Its core strategy revolves around a portfolio of orexin receptor 2 agonist programs, led by ORX750, targeting significant unmet needs in sleep-wake disorders and broader neuroscience indications. The company is led by a seasoned team of industry veterans and operates with a lean, asset-focused development model to drive programs from discovery to late-stage development efficiently.
View full company profileAbout Centessa Pharmaceuticals
Centessa Pharmaceuticals is a clinical-stage biotech company with a mission to discover and develop transformational medicines for patients. Its core strategy revolves around a portfolio of orexin receptor 2 agonist programs, led by ORX750, targeting significant unmet needs in sleep-wake disorders and broader neuroscience indications. The company is led by a seasoned team of industry veterans and operates with a lean, asset-focused development model to drive programs from discovery to late-stage development efficiently.
View full company profile